Signant unveils Oncology Complete to optimise oncology clinical trials
The new offering can be applied to any cancer programme from early-phase, local trials to pivotal multinational studies.
Company News
Latest in
Company News
Aerie doses first participant in Phase III dry eye disease therapy trial
Participants will be given the AR-15512 (0.003%) or AR-15512 vehicle as a drop dosed two times a day in each…
Junshi reports positive Phase III data in mild-to-moderate Covid-19
Participants in the VV116 arm showed a shorter time to sustained clinical recovery compared to those in the Paxlovid arm.
MMS partners with Thread for decentralised clinical trial platform
Thread is enabling clinical trials to be patient-centric and inclusive through its singular configurable platform.
Pierre Fabre, EORTC commence encorafenib/binimetinib Phase III melanoma trial
The trial will analyse if the combination treatment can extend recurrence-free survival versus placebo.
Biond doses first subjects in Phase I solid tumour therapy trial
The trial will analyse the safety, tolerability, PK, anti-tumour activity and exploratory biomarkers for BND-22 activity.
AmerisourceBergen unveils Clinical Trial Navigator to boost community-based research
The solution suite merges oncology practices with trials using digital site selection, patient detection and enrolment tools.
Pfizer-BioNTech’s vaccine for Covid-19 offers immune response in children
In the trial, the vaccine efficacy was found to be 80.3% in children aged six months to below five years.